Data from trials of Baiya Phytopharm plant-based vaccine being studied for other applications
Thailand’s Baiya Phytopharm accepts that its Covid-19 vaccine production is too late for the latest coronavirus surge. However, the data from its research could help lead to new vaccines for cancer and other diseases, it says.
Baiya Phytopharm is the only pharmaceutical company in Asia that has developed a plant-based vaccine for Covid using Nicotiana benthamiana leaves.
Asst Prof Suthira Taychakhoonavudh, the co-founder of Baiya Phytopharm and a professor at…
